Advertisement
Advertisement
CLDX
Celldex Therapeutics, Inc
41.71
USDSponsored
+0.15
+0.36%
Aug 07, 15:59 UTC -4
Closed
After-Market
41.77
+0.05
+0.13%
Celldex Therapeutics, Inc Financial Snapshot
| Market Cap | 3.28B |
| Beta | 0.87 |
| Earnings Per Share (EPS) | -4.35 |
| Price-to-Book (P/B) Ratio | 7.15 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.17% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -57.00% |
| Current Ratio | 11.82% |
| Free Cash Flow | -127.82M |
Trending Stocks
Advertisement